ZYME - Zymeworks Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ZYME (1937653)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-01-19
ZYMEEcor1 Capital, LLC10%P - Purchase$9.70+307,5009,887,473+3%+$2,982,733
M
2023-01-13
ZYMEEcor1 Capital, LLC10%P - Purchase$9.84+985,1009,579,973+11%+$9,697,527
M
2023-01-10
ZYMEEcor1 Capital, LLC10%P - Purchase$7.67+1,026,3008,594,873+14%+$7,874,083
AD
2022-12-12
ZYMEAstle ChristopherSVP, CFOS - Sale+OE$6.01-8871,333-40%-$5,331
AD
2022-11-10
ZYMEJosephson NeilChief Medical OfficerS - Sale+OE$8.10-2,47514,449-15%-$20,045
D
2022-12-12
ZYMEAstle ChristopherSVP, CFOS - Sale+OE$6.01-8871,333-40%-$5,331
D
2022-11-10
ZYMEJosephson NeilChief Medical OfficerS - Sale+OE$8.10-2,47514,449-15%-$20,045
A
2022-10-13
ZYMERedmile Group, LLC10%P - Purchase$5.03+30,4816,075,918+1%+$153,435

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top